RAND's divisions conduct research on a uniquely broad front for clients around the globe.
More
Podcast
Jun 26, 2025
Duration 29:32
Jun 25, 2025
Most relevant regions
Research Summary
Oct 21, 2025
This brief presents the results of a study of U.S. veterans’ access to, knowledge of, and use of contraception and contraceptive care to understand gaps in access and choice for veterans and how these gaps might vary by certain characteristics.
Research
Oct 20, 2025
The purpose of this paper is to outline development and evaluation methodology for a comparative effectiveness trial of two virtual, culturally grounded, brief interventions to address suicide prevention among Alaska Native young people.
Oct 15, 2025
This multi-method evaluation of SNAP-Ed programs in L.A. County provides insights into both the associations between program participation and dietary behaviors and the implementation factors that influence program delivery.
Duration 28:51
More than one in eight Americans know someone who has died of a drug overdose. RAND's Alison Athey shares what's behind the numbers.
Oct 13, 2025
Extending prior research, we analyzed more recent effects of Affordable Care Act Medicaid expansions on specialty substance use disorder treatment, using 2010-22 all-payer data on treatment episodes.
Oct 3, 2025
First-year US OTC naloxone sales were low, peaking then stabilizing far below pharmacy or program distribution rates. High prices and limited uptake suggest OTC access has not filled distribution gaps; further research on demand drivers is needed.
Oct 2, 2025
Medicaid unwinding led to more buprenorphine treatment episodes ending (+3%) and fewer starting (-2.6%) among Medicaid patients, with greatest impact in high-disenrollment states; losses were not offset by other payers, risking treatment disruption.
Oct 1, 2025
RAND equips policymakers with rigorous analysis and original data on cannabis, opiates, and psychedelics to help them make informed, evidence-based decision.
RAND Health research explores novel approaches to behavioral health treatment to improve mental health and reduce substance use disorders.
Expert Insights
Sep 30, 2025
Testimony submitted to the New York State Assembly Standing Committee on Health on September 30, 2025.
Press
Sep 29, 2025
The end of pandemic-era enrollment enhancements for Medicaid was associated with a rise in the number of people ending medication treatment for opioid use disorder, as well as a decrease in the number of people beginning such treatment.
Sep 26, 2025
Larger per capita opioid settlement disbursements are associated with greater reductions in opioid overdose deaths, and states with higher prior death rates receive more funds early in implementation.